6BVH image
Deposition Date 2017-12-13
Release Date 2018-12-19
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6BVH
Title:
Trypsin complexed with a modified sunflower trypsin inhibitor, SFTI-TCTR(N12,N14)
Biological Source:
Source Organism:
Helianthus annuus (Taxon ID: 4232)
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
1.93 Å
R-Value Free:
0.15
R-Value Work:
0.13
R-Value Observed:
0.13
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cationic trypsin
Gene (Uniprot):PRSS1
Chain IDs:A
Chain Length:223
Number of Molecules:1
Biological Source:Bos taurus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Trypsin inhibitor 1
Mutagens:R2T, K4R, F12N, D14N compared to UNP Q4GWU5, residues 40-53
Chain IDs:B (auth: I)
Chain Length:14
Number of Molecules:1
Biological Source:Helianthus annuus
Primary Citation
Potent, multi-target serine protease inhibition achieved by a simplified beta-sheet motif.
PLoS ONE 14 e0210842 e0210842 (2019)
PMID: 30668585 DOI: 10.1371/journal.pone.0210842

Abstact

Engagement of an extended β-sheet is a common substrate/inhibitor interaction at the active site of serine proteases and is an important feature of Laskowski mechanism inhibitors that present a substrate-like loop to a target protease. This loop is cleaved but subsequently relegated forming a stable inhibitor/protease complex. Laskowski inhibitors are ubiquitous in nature and are used extensively in serine protease inhibitor design. However, most studies concentrate on introducing new sidechain interactions rather than the direct contributions of the substrate-like β-sheet to enzyme inhibition. Here we report the crystal structure of an simplified β-sheet inhibitory motif within the Sunflower Trypsin Inhibitor (SFTI) in complex with trypsin. We show that the intramolecular hydrogen bond network of this SFTI variant (SFTI-TCTR) engages the inhibitor sidechains that would normally interact with a target protease, giving mainchain interactions a more prominent role in complex formation. Despite having reduced sidechain interactions, this SFTI variant is remarkably potent and inhibits a diverse range of serine proteases. Crystal structural analysis and molecular modelling of SFTI-TCTR complexes again indicates an interface dominated by β-sheet interactions, highlighting the importance of this motif and the adaptability of SFTI as a scaffold for inhibitor design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures